These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1385137)

  • 1. Changes in prostate-specific antigen and prostatic acid phosphatase concentration following prostatic examination in benign prostatic hypertrophy and prostate cancer patients.
    Romics I; Galamb L
    Eur Urol; 1992; 21 Suppl 1():83-6. PubMed ID: 1385137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between prostatic acid phosphatase and prostate-specific antigen serum levels and prostatic volume in benign prostate hyperplasia. Pitfall on tumor markers assessment in primary prostatic cancer?
    Omacini S; Mione R; Barichello M; Santucci Delli Ponti U; Bolgan A; Contemori GP; Petracco S; Capitanio G; Donisi PM; Gion M
    Eur Urol; 1992; 21 Suppl 1():108-10. PubMed ID: 1385128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of manipulation of the prostate gland on serum prostate-specific acid phosphatase measured by radioimmunoassay.
    Vihko P; Lukkarinen O; Kontturi M; Vihko R
    Invest Urol; 1981 Mar; 18(5):334-6. PubMed ID: 6162819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of prostatic massage on serum levels of prostatic acid phosphatase and specific antigen].
    Sahin A; Ozen H; Balbay D; Bircan K; Koray Z; Karaagaoglu E; Remzi D
    Bull Cancer; 1992; 79(11):1097-100. PubMed ID: 1284587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4-10 ng/ml.
    Martínez-Piñeiro L; Tabernero A; Contreras T; Madero R; Lozano D; López-Tello J; Alonso-Dorrego JM; Picazo ML; González Gancedo P; Martínez-Piñeiro JA; de La Peña JJ
    Eur Urol; 2000 Mar; 37(3):289-96. PubMed ID: 10720854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
    Filella X; Molina R; Jo J; Umbert B; Bedini JL; Ballesta AM
    Tumour Biol; 1990; 11(6):289-94. PubMed ID: 1700860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of digital rectal examination, flexible cystoscopy and prostatic biopsy on free and total prostate specific antigen, and the free-to-total prostate specific antigen ratio in clinical practice.
    Collins GN; Martin PJ; Wynn-Davies A; Brooman PJ; O'Reilly PH
    J Urol; 1997 May; 157(5):1744-7. PubMed ID: 9112518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of prostate-specific antigen and prostate-specific antigen density with outcome of prostate biopsy.
    Bare R; Hart L; McCullough DL
    Urology; 1994 Feb; 43(2):191-6. PubMed ID: 7509526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue polypeptide-specific antigen: a discriminative parameter between prostate cancer and benign prostatic hypertrophy.
    Marrink J; Oosterom R; Bonfrer HM; Schröder FH; Mensink HJ
    Eur J Cancer; 1993; 29A(4):570-1. PubMed ID: 7679580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate specific antigen and prostate specific antigen density. Roles in patient evaluation and management.
    Benson MC; Olsson CA
    Cancer; 1994 Sep; 74(6):1667-73. PubMed ID: 7521783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum PSA and PAP measurements discriminating patients with prostate carcinoma from patients with nodular hyperplasia.
    Shih WJ; Collins J; Mitchell B; Wierzbinski B
    J Natl Med Assoc; 1994 Sep; 86(9):667-70. PubMed ID: 7525979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of various examination methods in the management of prostatic cancer].
    Romics I; Kaldenbach R; Bach D
    Orv Hetil; 1994 May; 135(22):1191-4. PubMed ID: 7517027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of tumor markers in the diagnosis of prostatic cancer].
    Casas Terrón E; Mari Ruiz M; Molina Andreu E
    Arch Esp Urol; 1993 Mar; 46(2):99-103. PubMed ID: 7684585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comment on Grond, A., M. Ostermann-Myrau: Benign and malignant diseases of the prostate].
    Grond A
    Versicherungsmedizin; 1995 Apr; 47(2):66-7. PubMed ID: 7539193
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate specific antigen density: a method for differentiating prostate carcinoma from benign prostatic hypertrophy demonstrates ethnic variation.
    Martin AA; Clejan S
    J La State Med Soc; 1994 Apr; 146(4):163-71. PubMed ID: 7516401
    [No Abstract]   [Full Text] [Related]  

  • 16. [BIOMARKERS OF EARLY AND DIFFERENTIAL DIAGNOSIS OF PROSTATIC CANCER].
    Grygorenko VM; Danylets RO; Vikarchuk MV; Gorbahn LV; Klepko AV
    Klin Khir; 2017; (1):54-7. PubMed ID: 30272918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of digital rectal examination on plasma prostate-specific antigen (PSA).
    Dutkiewicz S; Stepień K; Witeska A
    Int Urol Nephrol; 1996; 28(2):211-4. PubMed ID: 8836791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical behavior of prostatic specific antigen and prostatic acid phosphatase: a comparative study.
    Morote Robles J; Ruibal Morell A; Palou Redorta J; de Torres Mateos JA; Soler Roselló A
    Eur Urol; 1988; 14(5):360-6. PubMed ID: 2458936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
    Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H
    Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of PSA density (PSAD) in the differential diagnosis between prostatic adenocarcinoma and benign ++ prostatic hypertrophy].
    Tiranti D; Annoscia S; Montefiore F; Boccafoschi C
    Arch Ital Urol Androl; 1994 Sep; 66(4 Suppl):59-63. PubMed ID: 7534168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.